| Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance X Deng, A Achari, S Federman, G Yu, S Somasekar, I Bártolo, S Yagi, ... Nature microbiology 5 (3), 443-454, 2020 | 146 | 2020 |
| Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic I Bártolo, C Rocha, J Bartolomeu, A Gama, R Marcelino, M Fonseca, ... Infection, Genetics and Evolution 9 (4), 672-682, 2009 | 70 | 2009 |
| Baseline susceptibility of primary HIV-2 to entry inhibitors P Borrego, R Calado, JM Marcelino, I Bártolo, C Rocha, P Cavaco-Silva, ... Antiviral therapy 17 (3), 565-570, 2012 | 63 | 2012 |
| Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus … R Antunes, S Figueiredo, I Bártolo, M Pinheiro, L Rosado, I Soares, ... Journal of clinical microbiology 41 (7), 3361-3367, 2003 | 59 | 2003 |
| Evolutionary and structural features of the C2, V3 and C3 envelope regions underlying the differences in HIV-1 and HIV-2 biology and infection H Barroso, P Borrego, I Bártolo, JM Marcelino, C Família, A Quintas, ... PloS one 6 (1), e14548, 2011 | 47 | 2011 |
| High genetic diversity of human immunodeficiency virus type 1 in Angola I Bártolo, M Epalanga, J Bartolomeu, M Fonseca, A Mendes, A Gama, ... AIDS Research & Human Retroviruses 21 (4), 306-310, 2005 | 45 | 2005 |
| Keratinocyte growth factor-based strategies for wound re-epithelialization I Bártolo, RL Reis, AP Marques, MT Cerqueira Tissue Engineering Part B: Reviews 28 (3), 665-676, 2022 | 38 | 2022 |
| Origin and epidemiological history of HIV-1 CRF14_BG I Bartolo, AB Abecasis, P Borrego, H Barroso, F McCutchan, P Gomes, ... PLoS One 6 (9), e24130, 2011 | 37 | 2011 |
| HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique I Bártolo, J Casanovas, R Bastos, C Rocha, AB Abecasis, E Folgosa, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 51 (3), 323-331, 2009 | 36 | 2009 |
| Noncovalent PEG coating of nanoparticle drug carriers improves the local pharmacokinetics of rectal anti-HIV microbicides R Nunes, F Araujo, L Barreiros, I Bartolo, MA Segundo, N Taveira, ... ACS applied materials & interfaces 10 (41), 34942-34953, 2018 | 32 | 2018 |
| Antiretroviral drug resistance surveillance among treatment-naive human immunodeficiency virus type 1-infected individuals in Angola: evidence for low level of transmitted drug … I Bártolo, C Rocha, J Bartolomeu, A Gama, M Fonseca, A Mendes, ... Antimicrobial agents and chemotherapy 53 (7), 3156-3158, 2009 | 31 | 2009 |
| HIV-1 diversity, transmission dynamics and primary drug resistance in Angola I Bártolo, S Zakovic, F Martin, C Palladino, P Carvalho, R Camacho, ... PloS one 9 (12), e113626, 2014 | 29 | 2014 |
| Pyromellitic dianhydride crosslinked soluble cyclodextrin polymers: Synthesis, lopinavir release from sub-micron sized particles and anti-HIV-1 activity O Adeoye, I Bártolo, J Conceição, AB da Silva, N Duarte, AP Francisco, ... International Journal of Pharmaceutics 583, 119356, 2020 | 27 | 2020 |
| Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique C Palladino, V Briz, JM Bellón, I Bartolo, P Carvalho, R Camacho, ... PLoS One 8 (12), e82718, 2013 | 27 | 2013 |
| Synthesis and structure-activity relationships of new chiral spiro-β-lactams highly active against HIV-1 and Plasmodium NG Alves, I Bártolo, AJS Alves, D Fontinha, D Francisco, SMM Lopes, ... European Journal of Medicinal Chemistry 219, 113439, 2021 | 25 | 2021 |
| Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response C Rocha, R Calado, P Borrego, JM Marcelino, I Bártolo, L Rosado, ... Retrovirology 10, 1-14, 2013 | 25 | 2013 |
| Spiro-lactams as novel antimicrobial agents AJS Alves, NG Alves, CC Caratão, MIM Esteves, D Fontinha, I Bártolo, ... Current Topics in Medicinal Chemistry 20 (2), 140-152, 2020 | 22 | 2020 |
| Antiretroviral treatment of HIV-2 infection: available drugs, resistance pathways, and promising new compounds I Moranguinho, N Taveira, I Bártolo International Journal of Molecular Sciences 24 (6), 5905, 2023 | 19 | 2023 |
| Seronegative infection and AIDS caused by an A2 subsubtype HIV-1 AR Cardoso, C Gonçalves, D Pascoalinho, C Gil, AF Ferreira, I Bártolo, ... Aids 18 (7), 1071-1074, 2004 | 18 | 2004 |
| On the contribution of Angola to the initial spread of HIV-1 AC Pineda-Peña, J Varanda, JD Sousa, K Theys, I Bártolo, T Leitner, ... Infection, Genetics and Evolution 46, 219-222, 2016 | 17 | 2016 |
